Physician profile
Sanjiv Bais
NPI 1528065315
$3,663.86
in general payments reported to CMS, 2019-2025
31 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2021: $413 · 2022: $222 · 2023: $335 · 2024: $617 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,805 · Travel and Lodging: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,804.82 |
| Travel and Lodging | $687.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $895.85 | 2021-2025 | Interstim |
| Intuitive Surgical, INC. | $406.45 | 2019-2025 | Da Vinci Surgical System |
| Kerecis Limited | $335.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $301.32 | 2019-2025 | Oasis, Grafix, Stravix |
| Zimmer Biomet Holdings, INC. | $231.24 | 2023-2024 | Ribfix Blu Advantage |
| Abbvie INC. | $220.36 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Stryker Corporation | $162.39 | 2021-2025 | Spy-Phi System |
| Inari Medical, INC. | $141.69 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $118.41 | 2021 | |
| Acell, INC. | $95.97 | 2019 | |
| Braintree Laboratories, INC. | $80.43 | 2022-2024 | Sutab, Suflave |
| Solventum Corporation | $66.36 | 2024 | Abthera Advance, V.A.C. Veraflo Cleanse Choice, Prevena |
| Takeda Pharmaceuticals U.S.A., INC. | $61.44 | 2022-2023 | Gattex |
| Vertex Pharmaceuticals Incorporated | $60.05 | 2025 | |
| Heron Therapeutics, INC. | $58.06 | 2022-2023 | Zynrelef |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $45.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $44.49 | 2019-2025 | Exparel |
| Baxter Healthcare | $41.00 | 2022 | |
| Organogenesis INC. | $40.33 | 2022 | |
| Davol INC. | $34.21 | 2023 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $26.19 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $25.49 | 2019 | |
| Axonics, INC. | $21.01 | 2024 | Axonics |
| Abbott Laboratories | $17.89 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.82 | 2021 | |
| Acera Surgical, INC. | $15.61 | 2024 | Restrata Wound Matrix |
| Tela Bio, INC. | $14.15 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.76 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.62 | 2021 | |
| Merck Sharp & Dohme LLC | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjiv Bais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.